Member Info for bewise

If we have a C19 success it will be transformational for the sp imo. Lets see what the new year brings!

Good publicity for us!

With out a shadow of a doubt in my opinion once the C19 results are announced, if positive a partner will appear. Such a huge and lucrative market $$$$

ps....the health need is pretty immediate and not two years down the road therefore fast tracking is the only solution...

Imo this will be brought to market quickly if successful, i discern the indicator clue is in the ceo statement....

"If the pilot study is successful, we are committed to progressing ensifentrine as a treatment for COVID-19 and, if approved, increasing supplies to meet public health needs.”

A quick turn around to get this started, i get a sense of urgency from the RNS. If successful imo i can see this being fast tracked by FDA and on the market within months due to its already proven safety profile and entering P3 for copd.

A Covid 19 success would place us on the map in so many ways , all eyes would be on us.

In my speculative opinion I can envisage that if the Covid-19 test meets all end points the FDA could fast track this as we are already moving into P3 for copd. What do others think? $$$$

Things are moving well Buddy and in the right direction, the top team are competent. Sentiment is rising and we are moving out of the doldrums at last. Ensifentrine will be much sought after as its profile has been significantly raised with the forthcoming C19 test. As i have said the sp will inflate considerably if ensifentrine meets its end point in relation to C19.

The price will eventually hold past a £. If successful on C19 the sp will eventually hold past £££

I wouldn't get to caught up with the daily sp shenanigans...if ensifentrine helps C19 patients this sp will inflate..

Rising nicely pre mark in the States!

Spot on, a potentially very effective treatment with very few other options on the market $$$$. If this pivot trial is successful then a substantially higher share price.

A few thoughts: C19 is running rampant in the States and winter is approaching, Coronavirus cases are rising in Europe even in the summer heat, this thing is not going away any time soon and we will be living with it for some time/years to come. Imo i would imagine if ensifentrine proves successful in this test and i can't see why it wouldn't with all the previous positive test results- Will ensifentrine be fast tracked by the FDA to provide relief and speed up the recovery of patients? Its dual action is unique and there are not too many treatments out there(hens teeth)
I believe there will be a scramble for this compound amongst large pharms...

Imo opinion Verona were able to secure funding during this economic crisis because of the potential of ensifentrine in the fight against C19 and other major respiratory diseases & massive earning potential $$$$, what major drug company would not want ensifentrine in its books. Ensifentrine is extremely safe and well tolerated and provides significant benefits to patients.

The market is realizing the value ensifentrine and this cheap sp. We should storm past a £ imo and back to the level we should of always been at £1.50 +. The funding issue has now been sorted so a clear road ahead. The world needs ensifentrine in this dreadful pandemic...

Imo they are States centric, a larger and more lucrative market $$$ but no doubt in the fullness of time the NHS will benefit along with the rest of the world. $£€ :)

Thanks Buddy, yes I can see the Times article on the net. If ensifentrine proves successful against the after effects of Covid 19 a rocket will be placed under this share price. This will be big news!

Some press coverage in the Daily Mail today re Verona's Covid19 announcement, just need some BBC coverage now :)

Not a bad finish in the states..imo don't get to bothered about the weekly or monthly share price movement, we are closer to the end now and if successful in P3 and with other strings to our bow now we have a valuable and desirable asset. :)